BEUDAMED
    10,000 results · 26ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: Eu Ivd General ×

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR HLA CLASS II DETERMINANTS

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR LYMPHOCYTE SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR LYMPHOCYTE SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market